An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
Clinical trial NCT03478930 · COMPLETED
Trial details
- NCT number
- NCT03478930
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-09
- Primary completion
- 2020-03-16
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.